Last year, AngioDynamics Inc generated 160.93M USD for its biggest-performing segment, Endovascular Therapies. The United States made the largest contribution, accounting for 250.98M USD last year. For the latest quarter, AngioDynamics Inc reported the revenue of 41.48M USD for the period ending 2022-05-31, which came from the top-performing segment, Endovascular Therapies. United States contributed the highest revenue, at 73.59M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Endovascular Therapies

Vascular Access

Oncology/Surgery

Vascular Interventions & Therapies

FY2022

FY2021

FY2020

Endovascular Therapies

160.93M(50.89%)

121.43M(41.73%)

98.97M(37.46%)

Vascular Access

100.19M(31.68%)

101.31M(34.81%)

94.30M(35.70%)

Oncology/Surgery

55.10M(17.42%)

54.62M(18.77%)

57.15M(21.64%)

Vascular Interventions & Therapies

--(--)

13.65M(4.69%)

13.74M(5.20%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

250.98M(85.81%)

251.49M(82.75%)

282.71M(83.46%)

265.96M(84.11%)

237.04M(81.46%)

207.98M(78.73%)

216.96M(80.17%)

International

41.52M(14.19%)

52.43M(17.25%)

56.04M(16.54%)

50.26M(15.89%)

53.97M(18.54%)

56.18M(21.27%)

53.68M(19.83%)